PIM3 kinase, which belongs to the Ca2+/calmodulin-dependent protein kinase (CaMK) group, exhibits serine/threonine kinase activity.
Physiologically Relevant, Reproducible, Human Disease Models • Comprehensive, Curated, Reference Database • Powerful, Predictive Analytical Tools
Making the Vehicle for Gene Therapies
Expertise and Project Support of Any Size for Your Antibody Discovery Programs
Research and Discovery Solutions
Eurofins Discovery has developed a panel of novel LeadHunter® Src Homology 2 (SH2) domain-binding assays targeting Signal Transducer and Activation of Transcription (STAT) proteins (STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6) used in drug discovery therapeutics research for cancer, inflammation and autoimmune diseases.
Explore Drug Knowledge in Pathological Phenotypes and Targets
Evaluate Molecular Binding by Biacore 8K+
Biosimilarity assessment and relative potency determination by Biacore 8K+.
Structure determination for large proteins and complexes in drug discovery.
The Eurofins Discovery Protein Degradation and PROTAC Discovery Portfolio includes a comprehensive suite of target-based, cellular, and phenotypic approaches for a powerful drug discovery resource in the targeted protein degradation space.
Reliable chemistry, target-based and cellular functional services, and products to help you design successful and fully tailored screening cascades